Fighting Tumors with Varian’s FLASH Technology

Fighting Tumors with Varian’s FLASH Technology

MPO's Sean Fenske speaks with Dr. Deepak Khuntia of Varian about the firm’s one-second radiation system for tumors.

By Sean Fenske, Editor-in-Chief01.27.22
In this episode of Medtech Matters, a podcast focused on the medical device manufacturing industry and the factors impacting it, we speak with Dr. Deepak Khuntia, chief medical officer and senior VP of Medical Affairs at Varian. He offers insights on the company’s FLASH technology* and the significant differences between it and other radiation treatment systems. Dr. Khuntia also provides information about a clinical trial taking place to better understand the effect the FLASH system has on surrounding tissue. Specifically, the following questions are addressed.

  • You’re currently conducting a clinical trial on your FLASH therapy. Can you explain what the technology is and what it’s used for?
  • How does this treatment compare with more traditional methods for addressing this condition?
  • Are there future potential applications where the FLASH technology could be used?
  • Is this the first clinical trial incorporating the technology? I’m curious as to the response/feedback from physicians.
  • In terms of the Flash technology, or Varian on the whole, what’s ahead? What are the next steps?

Listen to this episode and see what you think of Varian’s FLASH technology. If you’d like to share thoughts, ask questions, or suggest a future participant for Medtech Matters, please reach out to me at sfenske@rodmanmedia.com.

Listen to the podcast streaming via the player or get the podcast on the Medtech Matters channel via your preferred vendor of podcasts, such as Apple Podcasts (iTunes) or Spotify.

Click here to review other podcasts.

*Note: FLASH therapy is under development and is not available for commercial sale.
Related Searches: